Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…ase inhibition (DNMTi) using azacytidine (AZA), zebularine, and GSK3685032, added during GMP-compatible manufacturing of B7-H3 -targeting …
…ma tumors and seven days later intravenously (IV) injected with KLG3BBz-huC825 or non-transduced (NT) T cells. We performed weekly [ 8 6Y]Y-AB…
…ed in co-cultures of SLC1A5-NK cells and GBM43 treated with the bispecific antibody. The effectiveness and selectivity of this dual strategy are be…
…s atezolizumab, followed by maintenance with DC vaccination and atezolizumab, led to long-term survival in a subset of patients with ES-SCLC…
…o-cultured with mouse splenocytes in the presence of GM-CSF and CpG-A. After five days, the phenotype and function of the trained spl…
…nt with anal cancer previously treated with 5 agents, including nivolumab. The duration of the complete responses is 8 months and 9 month…
…xperienced CD8 T cells in i.c. and s.c. SB28 compared to ICB or NOX-A12 monotherapy. Additionally, the combination treatment increased …
…an age was 63.8 years. The most common first-line regimens were nivolumab (N) + cabozantinib (44.1%), N + ipilimumab (26.5%), pembrolizum…
… of definitive surgery who had received chemotherapy along with Pembrolizumab as neoadjuvant settings. After the definitive surgery the biops…
…with PD-L1 blockade. The EORTC-1508GCG phase II trial evaluated atezolizumab (anti-PD-L1), bevacizumab (anti-VEGF), and low-dose aspirin in …
… exome and RNA sequencing of surgically resected tumor tissues. GT601 will be administered intravenously between 8 to 12 weeks post-s…